CIK 0001868279 · Non-accelerated filer<br>Emerging growth company
ArriVent BioPharma, Inc.
Sign in to watch- Ticker
- AVBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 240-780-6356
- Business address
- 18 CAMPUS BLVD., SUITE 100, NEWTOWN SQUARE, PA, 19073-3269
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-19 | LaChapelle Robin Chief Operating Officer | Option exercise | +12,364 | $3.65 | $45K | 124,583 |
| 2024-09-19 | LaChapelle Robin Chief Operating Officer | Option exercise · Stock Option (right to buy) | −2,471 | 2,460 | ||
| 2024-09-19 | LaChapelle Robin Chief Operating Officer | Option exercise · Stock Option (right to buy) | −2,867 | 22,637 | ||
| 2024-09-19 | LaChapelle Robin Chief Operating Officer | Option exercise · Stock Option (right to buy) | −7,164 | 15,473 | ||
| 2024-09-19 | LaChapelle Robin Chief Operating Officer | Option exercise · Stock Option (right to buy) | −12,364 | 18,865 | ||
| 2024-09-19 | LaChapelle Robin Chief Operating Officer | Option exercise · Stock Option (right to buy) | −2,700 | 56,471 | ||
| 2024-05-16 | Hohneker John Director | Grant or award · Stock Option (right to buy) | +29,550 | 29,550 | ||
| 2024-04-22 | Peterson Kristine Director | Grant or award · Stock Option (right to buy) | +28,587 | 28,587 | ||
| 2024-01-30 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% owner | Conversion | +3,616,041 | 3,616,041 | ||
| 2024-01-30 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% owner | Conversion | +313,076 | 3,929,117 | ||
| 2024-01-30 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% owner | Purchase | +555,555 | $18.00 | $10.0M | 4,484,672 |
| 2024-01-30 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% owner | Conversion · Series A Preferred Stock | −55,000,000 | 0 | ||
| 2024-01-30 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% owner | Conversion · Series B Preferred Stock | −4,761,903 | 0 | ||
| 2024-01-30 | ORBIMED ADVISORS LLC Director | Conversion | +821,827 | 821,827 | ||
| 2024-01-30 | ORBIMED ADVISORS LLC Director | Conversion | +821,827 | 821,827 | ||
| 2024-01-30 | ORBIMED ADVISORS LLC Director | Conversion | +469,615 | 1,291,442 | ||
| 2024-01-30 | ORBIMED ADVISORS LLC Director | Conversion | +469,615 | 1,291,442 | ||
| 2024-01-30 | ORBIMED ADVISORS LLC Director | Purchase | +222,222 | $18.00 | $4.0M | 1,513,664 |
| 2024-01-30 | ORBIMED ADVISORS LLC Director | Purchase | +222,222 | $18.00 | $4.0M | 1,513,664 |
| 2024-01-30 | ORBIMED ADVISORS LLC Director | Conversion · Series A Preferred Stock | −821,827 | 0 |
Page 3 of 4 · 78 trades